Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. This will alert our moderators to take action Name Reason for reporting: Foul language Slanderous Inciting hatred against a certain community Others. Early Hum Dev. Genome Res. Type 'su cmssvc'.
nest...